RU2009111098A - METHOD FOR TREATING ALCOHOL, OPIUM AND TOBACCO DEPENDENCE "UNIVERSAL PSYCHOPHARMACOLOGICAL NEUROPHYSIOLOGICAL BLOCK" - Google Patents
METHOD FOR TREATING ALCOHOL, OPIUM AND TOBACCO DEPENDENCE "UNIVERSAL PSYCHOPHARMACOLOGICAL NEUROPHYSIOLOGICAL BLOCK" Download PDFInfo
- Publication number
- RU2009111098A RU2009111098A RU2009111098/15A RU2009111098A RU2009111098A RU 2009111098 A RU2009111098 A RU 2009111098A RU 2009111098/15 A RU2009111098/15 A RU 2009111098/15A RU 2009111098 A RU2009111098 A RU 2009111098A RU 2009111098 A RU2009111098 A RU 2009111098A
- Authority
- RU
- Russia
- Prior art keywords
- solution
- treatment
- amount
- dependence
- during
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ лечения алкогольной зависимости, зависимости от опиатов, табачной зависимости, включающий эмоционально-стрессовое воздействие, рефлексотерапию на пациента, суггестивную психотерапию и фармакологическое воздействие растворами пирогенала, антагониста опиатных рецепторов, азотно-кислого серебра либо Протаргола, закрепление эффекта за счет регулярного проведения реабилитационных мероприятий, отличающийся тем, что во время эмоционально-стрессового воздействия при лечении от опийной зависимости либо от алкоголизма внутривенно вводят раствор магния 25% в количестве от 4 до 6 см3, раствор никотиновой кислоты 1% в количестве от 0,5 до 3 см3, раствор хлорида натрия 0,9% в количестве от 5 до 12 см3, после первой процедуры при лечении от опийной зависимости перорально вводят раствор антагониста опиатных рецепторов, при лечении от алкоголизма назначают сенсибилизационную терапию препаратами дисульфирамового ряда и/или цианамидом, при лечении от табачной зависимости проводят орошение ротовой полости раствором азотно-кислого серебра концентрацией от 0,5 до 1% либо раствором Протаргола, далее проводят первую процедуру закрепления эмоционально-стрессового эффекта, во время которой пациенту внутримышечно вводят раствор пирогенала при лечении от алкогольной зависимости в количестве от 50 до 100 мкг, при лечении от опийной зависимости от 100 до 1 500 мкг, при лечении зависимости от табака в количестве от 30 до 70 мкг, во время последующих реабилитационных мероприятий закрепления эффекта вводят композицию, которую выбирают из смеси раствора магния 25% в количестве от 4 до 6 см3, раствор никотиновой кислоты 1% в количестве от 0,5 до 3 A method for the treatment of alcohol dependence, dependence on opiates, tobacco dependence, including emotional stress exposure, reflexology on a patient, suggestive psychotherapy and pharmacological effects with solutions of pyrogenal, an opiate receptor antagonist, nitric acid silver or Protargolum, fixing the effect through regular rehabilitation measures, characterized in that during emotional stressful treatment during treatment for opiate addiction or alcoholism intravenously a 25% magnesium solution is introduced in an amount of 4 to 6 cm3, a nicotinic acid solution of 1% in an amount of 0.5 to 3 cm3, a sodium chloride solution of 0.9% in an amount of 5 to 12 cm3, after the first procedure in the treatment of opium addictions, an opiate antagonist solution is orally administered, in the treatment of alcoholism, sensitization therapy with disulfiram drugs and / or cyanamide is prescribed, in the treatment of tobacco dependence, the oral cavity is irrigated with a solution of nitric acid silver with a concentration of 0.5 to 1% or Prota solution goals, then carry out the first procedure of fixing the emotional-stress effect, during which the patient is injected intramuscularly with a solution of pyrogenal in the treatment of alcohol dependence in an amount of from 50 to 100 μg, in the treatment of opium dependence from 100 to 1,500 μg, in the treatment of tobacco dependence in an amount of 30 to 70 μg, during subsequent rehabilitation measures to consolidate the effect, a composition is administered that is selected from a mixture of a solution of magnesium 25% in an amount of 4 to 6 cm3, a solution of nicotinic acid 1% in an amount of 0.5 to 3
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009111098/15A RU2444352C2 (en) | 2009-03-25 | 2009-03-25 | Method of treating alcoholic dependence and opium addiction 'universal psychopharmacological neurophysiological block' |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009111098/15A RU2444352C2 (en) | 2009-03-25 | 2009-03-25 | Method of treating alcoholic dependence and opium addiction 'universal psychopharmacological neurophysiological block' |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009111098A true RU2009111098A (en) | 2011-05-27 |
| RU2444352C2 RU2444352C2 (en) | 2012-03-10 |
Family
ID=44734273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009111098/15A RU2444352C2 (en) | 2009-03-25 | 2009-03-25 | Method of treating alcoholic dependence and opium addiction 'universal psychopharmacological neurophysiological block' |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2444352C2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2029541C1 (en) * | 1992-07-09 | 1995-02-27 | Юлия Тимофеевна Яценко | Method for treating alcoholic hangover-abstinence syndrome and suppressing inclination to alcohol |
| RU2290955C1 (en) * | 2005-05-13 | 2007-01-10 | Евгений Евгеньевич Щерба | Method for interrupting abstinence syndrome in patients at opium narcomania |
-
2009
- 2009-03-25 RU RU2009111098/15A patent/RU2444352C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2444352C2 (en) | 2012-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2992321T3 (en) | Compositions and methods for the prophylaxis and treatment of addictions | |
| JP2010520185A5 (en) | ||
| ES2729679T3 (en) | Morphinan derivatives for the treatment of drug overdose | |
| EA200501420A1 (en) | DELIVERY DEVICE FOR DRUG AND CELL THERAPY | |
| TWI661827B (en) | Treatment and prevention of sleep disorders | |
| RU2012118974A (en) | COMBINATIONS OF PI3K INHIBITOR AND MEK INHIBITOR | |
| CA2998518A1 (en) | Treatment of addiction and dependency | |
| EA200870325A1 (en) | MEDICAL FORMS FOR THE INTRODUCTION OF COMBINATIONS OF MEDICINES | |
| WO2001093852A3 (en) | Method of treating pain using nalbuphine and opioid antagonists | |
| BRPI0512893B8 (en) | methods of determining the effectiveness of therapy in the treatment of amyloidosis and identifying a patient as a prodromal for disease associated with amyloid deposition and its compounds | |
| HUP0301773A2 (en) | Apomorphine derivatives and methods for their use | |
| EA200870449A1 (en) | TREATMENT OF INFLAMMATORY AND ULCERAL INTESTINAL DISEASES WITH OPIOUS ANTAGONISTS | |
| EA200700214A1 (en) | MEMANTINE AS AN ADDITIONAL THERAPY FOR ATYPICAL ANTIPSYCHOTIC REMEDIES IN PATIENTS WITH SCHIZOPHRENIA | |
| FI3749308T3 (en) | Treatment of patients with classic fabry disease with migalastat | |
| JP2021193118A (en) | Composition and method for treatment of neuropsychiatric disorders | |
| MA28004A1 (en) | TREATMENT OF WEANING OF DEPENDENCE | |
| WO2008063563A3 (en) | Methods of treating keratin hyperproliferation disorders using mtor inhibitors | |
| RU2009111098A (en) | METHOD FOR TREATING ALCOHOL, OPIUM AND TOBACCO DEPENDENCE "UNIVERSAL PSYCHOPHARMACOLOGICAL NEUROPHYSIOLOGICAL BLOCK" | |
| KR102507891B1 (en) | Using palmitoylethanolamide in combination with opioids | |
| DE602006017728D1 (en) | CANCER TREATMENT BY AGENT AND 2-DEOXYGLUCOSE | |
| EA200802159A1 (en) | INTRODUCTION OF THE AGONIST-ANTAGONIST TO PATIENTS WITH OPIOID DEPENDENCE | |
| UA81689C2 (en) | Preoperative treatment of post operative pain with buprenorphine | |
| RU2003135123A (en) | METHOD FOR TREATING DRUG DEPENDENCIES | |
| JP2008508253A5 (en) | ||
| RU2014150946A (en) | METHOD FOR LOWER WEIGHT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110715 |
|
| FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20110810 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140326 |